Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 3,520 Shares of Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 3,520 shares of the stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $41.56, for a total value of $146,291.20. Following the completion of the sale, the chief executive officer owned 51,480 shares of the company’s stock, valued at approximately $2,139,508.80. This trade represents a 6.40% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Jack Bendheim also recently made the following trade(s):

• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.07, for a total value of $144,566.40.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.18, for a total value of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.27, for a total value of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.38, for a total value of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.03, for a total value of $28,021.00.
• On Thursday, September 18th, Jack Bendheim sold 7,022 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.26, for a total value of $282,705.72.
• On Wednesday, September 10th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.29, for a total value of $145,340.80.
• On Tuesday, September 9th, Jack Bendheim sold 14,080 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.33, for a total value of $567,846.40.

Phibro Animal Health Price Performance

Shares of PAHC stock opened at $41.86 on Friday. The firm has a market cap of $1.70 billion, a P/E ratio of 35.47, a P/E/G ratio of 1.24 and a beta of 0.83. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.76 and a quick ratio of 1.25. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $42.82. The firm has a fifty day moving average of $38.70 and a two-hundred day moving average of $29.79.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, August 27th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.05. The company had revenue of $378.70 million during the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. As a group, research analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in PAHC. National Bank of Canada FI acquired a new position in Phibro Animal Health during the 1st quarter worth $30,000. Financial Management Professionals Inc. acquired a new position in Phibro Animal Health during the 2nd quarter worth $32,000. EverSource Wealth Advisors LLC boosted its position in Phibro Animal Health by 7,671.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock worth $69,000 after acquiring an additional 2,685 shares during the period. Tower Research Capital LLC TRC boosted its position in Phibro Animal Health by 768.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company’s stock worth $118,000 after acquiring an additional 4,079 shares during the period. Finally, Quantbot Technologies LP boosted its position in Phibro Animal Health by 53.8% during the 1st quarter. Quantbot Technologies LP now owns 7,870 shares of the company’s stock worth $168,000 after acquiring an additional 2,754 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

PAHC has been the subject of several research reports. Bank of America lifted their target price on Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research report on Friday, August 29th. Weiss Ratings reiterated a “hold (c)” rating on shares of Phibro Animal Health in a research report on Tuesday, October 14th. Morgan Stanley set a $34.00 target price on Phibro Animal Health in a research report on Thursday, August 28th. Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 29th. Finally, JPMorgan Chase & Co. upgraded Phibro Animal Health from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $25.00 to $35.00 in a research report on Monday, July 7th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus price target of $28.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.